PMID: 3750246May 1, 1986Paper

Antibiotic prophylaxis in cardiothoracic surgery in the United Kingdom: current practice

Thorax
A P WilsonR N Grüneberg

Abstract

A survey was conducted of the current practice of antibiotic prophylaxis in cardiac surgery throughout the United Kingdom. Most surgeons (84%) use a regimen covering a broad spectrum of bacterial species that is continued for two to three days after the operation. The most used regimens are a combination of beta lactamase resistant penicillin with an aminoglycoside (44%) or a single broad spectrum cephalosporin (30%). Just 16% of surgeons preferred a narrow spectrum regimen effective against only the Gram positive organisms commonly responsible for postoperative infection in these patients. Antibiotic prophylaxis has been adopted by all cardiac surgeons in the United Kingdom but is sometimes continued longer than is indicated by the clinical or experimental evidence.

References

Mar 1, 1977·Antimicrobial Agents and Chemotherapy·I PhillipsK Shannon
Sep 1, 1978·The Journal of Antimicrobial Chemotherapy·S W Newsom
Jan 1, 1976·Surgery·R E ClarkC S Weldon
Jun 29, 1985·Lancet·A R PenkethD J Parker
Feb 1, 1985·Mayo Clinic Proceedings·G J Kontos, H V Schaff
Jan 1, 1973·Annual Review of Medicine·J F Burke
Jul 7, 1973·British Medical Journal·R BlowersJ D Abbott
Jan 18, 1968·The New England Journal of Medicine·J S GoodmanM G Koenig
Dec 1, 1982·The Thoracic and Cardiovascular Surgeon·M Turina
Sep 1, 1983·Reviews of Infectious Diseases·D H BorG H Friedland
Jan 1, 1984·The Journal of Antimicrobial Chemotherapy·T N Stanbridge, D J Greenall
Feb 1, 1980·Antimicrobial Agents and Chemotherapy·G L Archer, M J Tenenbaum
Jul 1, 1982·Progress in Cardiovascular Diseases·K H Mayer, S C Schoenbaum

❮ Previous
Next ❯

Citations

Mar 1, 1996·The Annals of Thoracic Surgery·R M El Oakley, J E Wright
Aug 3, 1999·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·D R LewisN M Brown
Dec 1, 1993·British Heart Journal·G W ParryF P Shabbo
Jul 12, 2003·The Journal of Hospital Infection·J B KendallG N Russell
Jul 1, 1988·The Journal of Hospital Infection·A P WilsonM F Sturridge
Aug 1, 1987·International Journal of Cardiology·F GuzmanR Freeman
Feb 10, 2004·Journal of Motor Behavior·Arnaud Badets, Yannick Blandin
Mar 20, 2010·Shinrigaku kenkyu : The Japanese journal of psychology·Yohei YamadaTetsuji Hirano
Jan 1, 1994·Annales Françaises D'anesthèsie Et De Rèanimation·J J LehotS Estanove

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.